To functionally confirm the relationship between HIF2α and the RNASET2 gene, we treated ccRCC cells with a HIF2α inhibitor PT2385, which inhibits the interaction between HIF2α and ARNT (also known as HIFβ) thus blocking the activity of HIF2α. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.